Supplementary Table 1 from A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer

Autor:	Robert M. Wenham, Johnathan Lancaster, Andrew Berchuck, Paula S. Lee, Laura J. Havrilesky, Gloria Broadwater, Miao Yu, William T. Barry, Deanna K. Teoh, Angeles Alvarez Secord
Rok vydání:	2023
DOI:	10.1158/1078-0432.22451087.v1
Popis:	PDF file, 73K, Extended Toxicity Information.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b36d01118f0c17b59fcdeae599778d6 https://doi.org/10.1158/1078-0432.22451087.v1 Zobrazit plný text záznamu